Decreased perifoveal sensitivity detected by microperimetry in patients using hydroxychloroquine and without visual field and fundoscopic anomalies

Journal of Ophthalmology

Volumn 2015, Issue , 2015, Pages

  Molina Martin A ^a   Pinero D P ^b,c   Perez Cambrodi R J ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b Hospital Internacional Medimar   (Spain)

^c UNIVERSITY OF ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925583852     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2015/437271     Document Type: Article

References (20)

1. R. M. Santaella and F. W. Fraunfelder, "Ocular adverse effects associated with systemic medications: recognition andmanagement," Drugs, vol. 67, no. 1, pp. 75-93, 2007.
2. R. V. Shearer and E. L. Dubois, "Ocular changes induced by long-term hydroxychloroquine (Plaquenil) therapy," American Journal of Ophthalmology, vol. 64, no. 2, pp. 245-252, 1967.
3. S. Mißner and U. Kellner, "Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography," Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 3, pp. 319-325, 2012.
4. A. E. Semmer, M. S. Lee, A. R. Harrison, and T. W. Olsen, "Hydroxychloroquine retinopathy screening," British Journal of Ophthalmology, vol. 92, no. 12, pp. 1653-1655, 2008.
5. K. Rohrschneider, S. Bültmann, and C. Springer, "Use of fundus perimetry (microperimetry) to quantify macular sensitivity," Progress in Retinal and Eye Research, vol. 27, no. 5, pp. 536-548, 2008.
6. J. C. S. Yam and A. K. H. Kwok, "Ocular toxicity of hydroxychloroquine," Hong KongMedical Journal, vol. 12, no. 4, pp. 294-304, 2006.
7. J. A. Rodriguez-Padilla, T. R. Hedges III, B. Monson et al., "High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy," Archives of Ophthalmology, vol. 125, no. 6, pp. 775-780, 2007.
8. W. Frederick and M. F. Marmor, "Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus," Arthritis Care and Research, vol. 62, no. 6, pp. 775-784, 2010.
9. M. F. Marmor, R. E. Carr, M. Easterbrook, A. A. Farjo, W. F. Mieler, and American Academy of Ophthalmology, "Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology," Ophthalmology, vol. 109, no. 7, pp. 1377-1382, 2002.
10. M. F. Marmor, U. Kellner, T. Y. Y. Lai, J. S. Lyons, and W. F. Mieler, "Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy," Ophthalmology, vol. 118, no. 2, pp. 415-422, 2011.
11. K. Rüther, J. Foerster, S. Berndt, and J. Schroeter, "Chloroquine/hydroxychloroquine: variability of retinotoxic cumulative doses," Ophthalmologe, vol. 104, no. 10, pp. 875-880, 2007.
12. M. Michaelides, N. B. Stover, P. J. Francis, and R. G. Weleber, "Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy," Archives of Ophthalmology, vol. 129, no. 1, pp. 30-39, 2011.
13. P. Salu, A. Uvijls, P. van den Brande, and B. P. Leroy, "Normalization of generalized retinal function and progression of maculopathy after cessation of therapy in a case of severe hydroxychloroquine retinopathy with 19 years follow-up," Documenta Ophthalmologica, vol. 120, no. 3, pp. 251-264, 2010.
14. R. Bergholz, J. Schroeter, and K. Rüther, "Evaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquine," British Journal of Ophthalmology, vol. 94, no. 12, pp. 1637-1642, 2010.
15. R. Tehrani, R. A. Ostrowski, R. Hariman, and W.M. Jay, "Ocular toxicity of hydroxychloroquine," Seminars in Ophthalmology, vol. 23, no. 3, pp. 201-209, 2008.
16. M. F. Marmor, "Fundus autofluorescence is not the best early screen for hydroxychloroquine toxicity," JAMA Ophthalmology, vol. 131, no. 11, pp. 1487-1488, 2013.
17. D. F. Farrell, "Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study," Clinical Ophthalmology, vol. 6, no. 1, pp. 377-383, 2012.
18. M. Angi, V. Romano, X. Valldeperas, F. Romano, and M. R. Romano, "Macular sensitivity changes for detection of chloroquine toxicity in asymptomatic patient," International Ophthalmology, vol. 30, no. 2, pp. 195-197, 2010.
19. L. Martínez-Costa, M. Victoria Ibañez, C. Murcia-Bello et al., "Use of microperimetry to evaluate hydroxychloroquine and chloroquine retinal toxicity," Canadian Journal of Ophthalmology, vol. 48, no. 5, pp. 400-405, 2013.
20. R. V. Jivrajka, M. A. Genead, J. J. Mcanany, C. C. Chow, and W. F. Mieler, "Microperimetric sensitivity in patients on hydroxychloroquine (Plaquenil) therapy," Eye, vol. 27, no. 9, pp. 1044-1052, 2013.